SecBot SecBot
144 ·Filed May 5, 2026

TVTX

Travere Therapeutics, Inc.
NEUTRAL
Impact 2/10
Horizonimmediate Processed6mo ago SEC0001193125-26-207083
Form 144, notice of proposed sale of securities
Actionable Insight • Neutral

This filing is routine and carries no directional signal. Monitor for any discretionary insider selling patterns in future filings, but no immediate action required.

DirectionNeutral
Confidencehigh
Horizonimmediate

How the stock moved after the report

⚠ Clustered NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60
Entry
$44.76
T+0 close · May 5, 2026 · via day close
Latest settled
+24.87%
T+60 · $55.89
Vs SPY
+22.80%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · May 6 $44.76entry
  2. T+1 · 6mo ago −4.69%α −4.36% · $42.66
  3. T+5 · 6mo ago −4.29%α −5.42% · $42.84
  4. T+20 · 6mo ago +0.98%α −1.80% · $45.20
  5. T+60 · 4mo ago +24.87%α +22.80% · $55.89

Price Chart

Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Elizabeth E. Reed, an officer of Travere Therapeutics, filed a Form 144 to sell 2,174 shares for approximately $101,417 to satisfy tax withholding obligations from vested performance restricted stock units. This is a mandatory, non-discretionary sale and does not reflect insider sentiment.

Key Facts

  • Filer: Elizabeth E. Reed, officer (likely General Counsel)
  • Shares to sell: 2,174
  • Approximate value: $101,417
  • Sale reason: Mandatory sell-to-cover for tax withholding on vesting of performance RSUs
  • Transaction is not discretionary

Financial Impact

Negligible relative to company's $4.1B market cap

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
90% bullish (21 analysts)

Investment Themes

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
144 Filing (Primary)0001193125-26-207083
Document: 0001193125-26-207083-index.html0001193125-26-207083
Document: 0001193125-26-207083.txt0001193125-26-207083

Track record

21 reports on TVTX

Performance horizon

8 of 10 bullish or bearish reports moved the stock their way by T+5. Best: +56.24% at T+60 after the Jun 2, 2026 report. 10 of 10 went positive at some point.

Filters
  1. Nov 16, 2026today SC 13G/A Neutral 2/10 Entry $50.30 Now $49.70 −1.19% settles Nov 23
  2. Nov 5, 202611d ago SC 13G/A Neutral 2/10 Entry $48.87 to $51.56 Now $49.70 +1.70% ▲ +5.50% +2.21% vs SPY
  3. Nov 3, 202613d ago Institutional Cluster Bullish 4/10 Entry $49.41 to $51.99 Now $49.70 +0.59% ▲ +5.22% +5.81% vs SPY
  4. Nov 2, 202614d ago 8-K Bullish 6/10 Entry $49.41 to $51.99 Now $49.70 +0.59% ▲ +5.22% +5.81% vs SPY
  5. Sep 17, 20268w ago Insider Cluster Bearish 4/10 Entry $62.76 to $59.44 Now $49.70 +20.81% ▲ +5.29% +6.56% vs SPY
  6. Jul 9, 202618w ago 8-K Neutral 2/10 Entry $56.59 to $55.28 Now $49.70 −12.18% ▼ −2.31% −1.75% vs SPY
  7. Jun 16, 202621w ago Insider Cluster Neutral 2/10 Entry $54.14 to $57.69 Now $49.70 −8.20% ▲ +6.56% +7.60% vs SPY
  8. Jun 16, 202621w ago 8-K Neutral 2/10 Entry $54.14 to $57.69 Now $49.70 −8.20% ▲ +6.56% +7.60% vs SPY
  9. Jun 12, 202622w ago 144 Neutral 2/10 Entry $52.04 to $55.15 Now $49.70 −4.50% ▲ +5.98% +5.30% vs SPY
  10. Jun 2, 202623w ago 8-K Bullish 6/10 Entry $42.96 to $48.57 Now $49.70 +15.69% ▲ +13.06% +16.02% vs SPY
Showing 10 of 21

US Market Status

Market Closed · Opens in 7h 59m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published May 5, 2026